Chronic wounds can be incredibly frustrating—for patients, families, and providers alike. Few conditions demonstrate this more clearly than diabetic foot ulcers. These wounds can persist for months or even years despite excellent conventional care and are among the leading causes of hospitalization, infection, and lower-extremity amputation in individuals living with diabetes.
Regenerative medicine is changing that story. Two of the most promising therapies available today are Platelet-Rich Plasma (PRP) and Platelet-Rich Fibrin (PRF), autologous biologic treatments that harness the body's natural healing potential.
At our practice, we've seen firsthand how PRP and PRF can accelerate tissue repair, improve outcomes, and restore hope.
Understanding Diabetic Foot Ulcers
Diabetes affects nearly every phase of wound healing. Elevated blood glucose can:
As a result, even minor injuries can become chronic, non-healing wounds.
Without effective intervention, diabetic foot ulcers may progress to serious infection, hospitalization, or even limb amputation.
Traditional wound care remains essential and includes:
For many chronic wounds, PRP and PRF can serve as powerful adjunctive therapies when conventional care alone is insufficient.
Understanding PRP and PRF
Platelet-Rich Plasma (PRP) and Platelet-Rich Fibrin (PRF) are advanced regenerative therapies created from a patient's own blood.
Both therapies concentrate platelets, growth factors, and healing cells to stimulate tissue repair. However, they differ in their preparation and release characteristics.
Platelet-Rich Plasma (PRP)
PRP is produced by centrifuging blood with anticoagulants to isolate a concentrated plasma layer rich in platelets. It delivers a rapid release of growth factors and is currently the only platelet concentrate approved by Medicare for certain diabetic wound applications.
Platelet-Rich Fibrin (PRF)
PRF is a next-generation platelet concentrate that requires no anticoagulants or additives. It forms a natural fibrin scaffold that gradually releases growth factors over time, making it especially effective for chronic wound management.
Together, PRP and PRF offer clinicians versatile regenerative options tailored to individual patient needs.
Case Study: PRF for a Chronic Diabetic Foot Ulcer
A 37-year-old woman presented with a plantar diabetic foot ulcer that had remained unhealed since 2022.
Patient Profile
Initial Wound Assessment
This type of wound often proves difficult to heal using standard therapies alone, making PRP and PRF important considerations in advanced wound care.
The PRF Treatment Protocol
For this particular case, Platelet-Rich Fibrin (PRF) was selected based on the wound characteristics and clinical goals.
The patient underwent weekly PRF applications using the following protocol:
Adjunctive Care Included
While both PRP and PRF are valuable tools, PRF was the ideal choice for this chronic wound due to its sustained release profile and fibrin scaffold.
Clinical Outcomes
The wound demonstrated significant improvement over eight weeks.
Week Four
Week Eight
Additional Outcomes
For a wound present for several years, this rate of healing was highly encouraging and reflects the regenerative potential of PRP and PRF therapies.
Why PRP and PRF Work
Both PRP and PRF deliver concentrated biologic mediators, including:
These growth factors stimulate:
PRP provides an immediate, concentrated release of growth factors, while PRF offers a prolonged, sustained delivery through its three-dimensional fibrin matrix.
This combination makes PRP and PRF highly effective across a broad range of wound care applications.
Medicare Coverage Considerations
It is important to note that Platelet-Rich Plasma (PRP) is currently the platelet concentrate approved by Medicare for specific diabetic wound indications when coverage criteria are met.
While PRF offers compelling clinical benefits and is widely utilized in regenerative medicine, providers should carefully verify payer policies and reimbursement guidelines prior to treatment.
Evidence-Based Support
Current research continues to validate the effectiveness of PRP and PRF in chronic wound management.
Clinical studies have demonstrated:
For diabetic foot ulcers, PRP and PRF are rapidly becoming invaluable adjuncts to comprehensive wound care.
Patient Experience
The patient reported minimal pain and high satisfaction throughout treatment.
She appreciated seeing visible progress each week and felt increasingly confident as healing advanced. As the wound improved, so did her ability to safely return to normal daily activities.
The Future of Regenerative Wound Care
Chronic wounds require innovative solutions. PRP and PRF provide safe, cost-effective, outpatient treatment options that leverage the body's own regenerative capacity.
For providers treating:
PRP and PRF represent powerful additions to the wound care toolbox.
Final Thoughts
Every chronic wound tells a story.
For this patient, PRF helped transform a prolonged, frustrating healing journey into one of measurable progress and renewed confidence.
As regenerative medicine continues to evolve, both PRP and PRF are poised to become cornerstones of advanced wound management and limb preservation.
If you're interested in learning whether PRP or PRF may be appropriate for your patients or practice, we'd be happy to discuss their applications further.